Menopause is known as the stage of the end of the fertile phase in women, which occurs typically at the age of 40 most women. Menopause affects reduced estrogen production and grown gonadotropin, which results in the termination of the menstrual cycle and menstrual flow. These physiological changes cause vasomotor symptoms. Vasomotor symptoms are changes between two phases that are peri-menopause and menopause.
MARKET DYNAMICS
Menopause treatment market is anticipated to grow in the forecast period owing to driving factors such as rise in geriatric population and growing awareness about women health. Moreover, development of healthcare and gynecology centres, and development in drugs specially the advancements in hormonal drugs etc. is also offering opportunity in the market growth during the forecast period.
MARKET SCOPE
The "Global Menopause Treatment Market Analysis to 2028" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of menopause treatment market with detailed market segmentation by hormonal treatment, non-hormonal treatment, end user, and geography. The global menopause treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading menopause treatment market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global menopause treatment market is segmented on the basis of hormonal treatment, non-hormonal treatment and end user. Based on hormonal treatment, the market is segmented as estrogen, progesterone, and combination. Based on non-hormonal treatment, the market is segmented as anti-depressants, anti-migraine, and anti-anxiety. Based on end user, the market is segmented as hospitals & clinics, academic & research institutes, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global menopause treatment market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The menopause treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting menopause treatment market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the menopause treatment market in these regions.
MARKET PLAYERS
The report covers key developments in the menopause treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from menopause treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for menopause treatment in the global market. Below mentioned is the list of few companies engaged in the menopause treatment market.
The report also includes the profiles of key menopause treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Merck & Co., Inc.
- Novartis AG
- Novo Nordisk A/S
- Pfizer, Inc.
- Allergan plc.
- Emcure Pharmaceuticals Ltd.
- Eli Lilly and Company
- Cipla Inc.
- Teva Pharmaceutical Industries Ltd.
- Glenmark Pharmaceuticals Ltd.